PINK:SPHDF

Santhera Pharmaceuticals Hldg Stock Signals

etoro logo Buy SPHDF
*Your capital is at risk
$23.25
+0 (+0%)
At Close: Jun 22, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Santhera Pharmaceuticals Hldg

General

Signal Type Signal Value Data
Score 0.000 105 days ( -48.75 %
Last Price $23.25 0 %
Performance History
7 Days
$23.25 $23.25
0%
30 Days
$23.25 $23.25
0%
12 Mos
$14.75 $23.25
57.63%

10/18

Active Buy Signals

Specific Signals

Short Term
Net score: 59.46
Signal Type Signal Value Importance Data
High / Low N/A Very Low $23.25 - $23.25
Trend - 3 mos 23.42 % High Width: 13.09 %
Pred. range - 3 mos $28.00 - $31.67 Low 20.44 % - 36.21 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Sell Very Low Jun 18, 2026 - 2 days
RSI Short Pivot Signal Sell Very Low May 05, 2026 - 33 days
Short MA 3 mos Sell Low Apr 23, 2026 - 41 days
Long MA 3 mos Buy Medium Apr 15, 2026 - 47 days
Short/Long MA 3 mos Buy Medium Apr 16, 2026 - 46 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 79.92
Signal Type Signal Value Importance Data
Trend - 12 mos 44.81 % Very High Width: 52.61 %
Pred. range - 12 mos $24.11 - $36.80 High 3.72 % - 58.29 %
Short MA 12 mos Buy Very High Apr 08, 2026 - 52 days
Long MA 12 mos Buy Very High Jan 15, 2026 - 108 days
Short/Long MA 12 mos Buy Very High Jan 27, 2026 - 101 days
Pivot Long Sell Low Jun 18, 2026 - 2 days
RSI Long Pivot Signal Buy Low Mar 19, 2026 - 65 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT SANTHERA PHARMACEUTICALS HLDG
Santhera Pharmaceuticals Hldg
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes vamorolone, which is being developed as treatments for Duchenne muscular dystrophy (DMD). Its clinical stage pipeline also comprises lonodeles...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE